International Patent: QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF AN IMMUNOLOGICAL DISEASE OR DYSFUNCTION, IN PARTICULAR OF CHRONIC GRAFT-VERSUS-HOST-DISEASE (CGVHD)

GENEVA, Oct. 30 -- QURIENT CO., LTD. filed a patent application (EP2026/061870) for “QUINOLINE DERIVATIVES FOR USE IN THE TREATMENT OF AN IMMUNOLOGICAL DISEASE OR DYSFUNCTION, IN PARTICULAR OF CHRONIC GRAFT-VERSUS-HOST-DISEASE (CGVHD)”. With publication no. WO/2026/224352, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/4709

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....